Search research articles
Contact Us
Filters
Showing results (161-170 of 180) with videos related to
Page
of 18
Sort By:
Transplantation and Cellular Therapy
|
September 19, 2021
Bone Marrow versus Peripheral Blood Grafts for Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide
Rohtesh S Mehta, Rima M Saliba, Leonard C Alsfeld, et al.
The Lancet. Haematology
|
November 4, 2018
Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trial
Uday R Popat, Rohtesh S Mehta, Roland Bassett, et al.
Nature Medicine
|
September 29, 2022
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape
Ye Li, Rafet Basar, Guohui Wang, et al.
Transplantation and Cellular Therapy
|
June 12, 2026
Randomized trial of two fractionation schedules of myeloablative busulfan with fludarabine and cladribine in AML or MDS
Uday R Popat, Konstantinos Lontos, Roland Bassett, et al.
Nature Medicine
|
January 5, 2024
Author Correction: KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape
Ye Li, Rafet Basar, Guohui Wang, et al.
Blood Cancer Discovery
|
October 27, 2025
CD70-Targeting CAR-NK Cells Overcome BCMA Downregulation and Improve Survival in High-Risk Multiple Myeloma Models
Paul Lin, Sunil Acharya, Francia Reyes-Silva, et al.
Cell Reports
|
July 16, 2021
Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapy
Rafet Basar, Nadima Uprety, Emily Ensley, et al.
Nature Medicine
|
June 26, 2025
Author Correction: Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial
Yago Nieto, Pinaki Banerjee, Indreshpal Kaur, et al.
Bone Marrow Transplantation
|
February 15, 2024
Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis
Alexandre E Malek, Taha Al-Juhaishi, Denái R Milton, et al.
Nature Medicine
|
April 4, 2025
Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial
Yago Nieto, Pinaki Banerjee, Indreshpal Kaur, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 180) with videos related to
Sort By:
Page
of 18
Transplantation and Cellular Therapy
|
September 19, 2021
Bone Marrow versus Peripheral Blood Grafts for Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide
Rohtesh S Mehta, Rima M Saliba, Leonard C Alsfeld, et al.
The Lancet. Haematology
|
November 4, 2018
Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trial
Uday R Popat, Rohtesh S Mehta, Roland Bassett, et al.
Nature Medicine
|
September 29, 2022
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape
Ye Li, Rafet Basar, Guohui Wang, et al.
Transplantation and Cellular Therapy
|
June 12, 2026
Randomized trial of two fractionation schedules of myeloablative busulfan with fludarabine and cladribine in AML or MDS
Uday R Popat, Konstantinos Lontos, Roland Bassett, et al.
Nature Medicine
|
January 5, 2024
Author Correction: KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape
Ye Li, Rafet Basar, Guohui Wang, et al.
Blood Cancer Discovery
|
October 27, 2025
CD70-Targeting CAR-NK Cells Overcome BCMA Downregulation and Improve Survival in High-Risk Multiple Myeloma Models
Paul Lin, Sunil Acharya, Francia Reyes-Silva, et al.
Cell Reports
|
July 16, 2021
Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapy
Rafet Basar, Nadima Uprety, Emily Ensley, et al.
Nature Medicine
|
June 26, 2025
Author Correction: Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial
Yago Nieto, Pinaki Banerjee, Indreshpal Kaur, et al.
Bone Marrow Transplantation
|
February 15, 2024
Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis
Alexandre E Malek, Taha Al-Juhaishi, Denái R Milton, et al.
Nature Medicine
|
April 4, 2025
Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial
Yago Nieto, Pinaki Banerjee, Indreshpal Kaur, et al.
Page
of 18